Long-term outcomes of laparoscopic sleeve gastrectomy from the Indian subcontinent

ConclusionWeight loss after LSG was maintained in the majority of the patients, while a small proportion has significant weight regain at 5  years. T2DM resolution and other comorbidity resolutions were well supported after LSG.
Source: Obesity Surgery - Category: Surgery Source Type: research

Related Links:

Some of the author affiliations were incorrectly assigned in the original article. They are correct here.
Source: Obesity Surgery - Category: Surgery Source Type: research
Preserving β-cell function is the major determinant of diabetes remission following laparoscopic sleeve gastrectomy in Japanese obese diabetic patients. Endocr J. 2019 Jun 01;: Authors: Ugi S, Morino K, Yamaguchi T, Yamamoto H, Kaida S, Miyazawa I, Sato D, Sekine O, Fujita Y, Kashiwagi A, Tani M, Maegawa H Abstract Laparoscopic sleeve gastrectomy has been proven effective in treating obesity-associated type 2 diabetes mellitus (T2DM). However, reports of the effect of laparoscopic sleeve gastrectomy on glucose metabolism in Japanese obese patients with T2DM are rare. The aim of this study was to e...
Source: Endocrine Journal - Category: Endocrinology Tags: Endocr J Source Type: research
AbstractIntroductionAvailable clinical data on the influence of baseline HbA1c postoperative morbidity and readmission after laparoscopic sleeve gastrectomy is scarce. This prompted us to conduct a multicenter retrospective study evaluating the influence of chronic hyperglycemia on postoperative course among patients undergoing laparoscopic sleeve gastrectomy (SG). We aimed to investigate the influence of baseline HbA1c levels on postoperative outcomes in patients after SG.Material and MethodsWe conducted a multicenter retrospective cohort study of consecutive patients who underwent SG from March 2017 to March 2018 in seve...
Source: Obesity Surgery - Category: Surgery Source Type: research
Conclusions: Bariatric surgery appears to be capable of partially reversing the obesity-related epigenome. The identification of potential epigenetic biomarkers predictive for the success of bariatric surgery may open new doors to personalized therapy for severe obesity. Introduction Obesity is currently a huge healthcare problem, worldwide, and is a risk factor for several diseases such as type 2 diabetes (T2D), cardiovascular disease and cancer (1). As the prevalence of obesity reaches pandemic proportions, this metabolic disease is estimated to become the biggest cause of mortality in the near future (2). In fact,...
Source: Frontiers in Endocrinology - Category: Endocrinology Source Type: research
ConclusionWhen confounders were taken into account, there appeared no significant associations between the BMI of patients with specific benign or pre-malignant histopathology compared with the BMI of the rest of the patients with abnormal histopathologies and compared to the BMI of patients with normal histopathologies of their gastric specimens. There was a very weak correlation between BMI and other covariates.
Source: Obesity Surgery - Category: Surgery Source Type: research
Background: Laparoscopic adjustable gastric banding (LAGB) and laparoscopic sleeve gastrectomy (LSG) are common weight loss procedures. Our meta-analysis compared these procedures for the treatment of morbid obesity and related diseases. Methods: We systematically searched the PubMed, Embase, and the Cochrane Library through January 2018. The percentage of excess weight loss (%EWL), improvement or remission of type 2 diabetes mellitus (T2DM) and hypertension were analyzed and compared. Results: Thirty-three studies with 4109 patients were included. Greater decreases in excess weight were found in patients who recei...
Source: Medicine - Category: Internal Medicine Tags: Research Article: Systematic Review and Meta-Analysis Source Type: research
ConclusionSynchronous VHR and BS in a bariatric unit is feasible with low recurrence rate. Laparoscopic VHR has lower complication rates than open, apart from seroma formation. Patients with diabetes have higher risk of infection.
Source: Surgical Endoscopy - Category: Surgery Source Type: research
Diabetes mellitus is an epidemic disease and is estimated to affect over 300 million people worldwide in 2025 [1]. Type 2 diabetes mellitus (T2D) management is a combination of diet, lifestyle modifications and drug therapy. Recently, many studies had shown remission of T2D in obese population [2-6]. Buchwald et al [2] in his systemic review and meta-analysis showed that diabetes remission rates were 99% (95% confidence interval (CI), 97-100%) after biliopancreatic diversion (BPD), 84% (95% CI, 77-90%) after Roux-en-Y gastric bypass (RYGB) and 48% (95% CI, 29-67%) after gastric banding.
Source: Surgery for Obesity and Related Diseases - Category: Surgery Authors: Tags: ORIGINAL ARTICLE Source Type: research
ConclusionLSG has a significant effect on patients with type 2 diabetes mellitus whose BMI less than 30  kg/m2 in a short time, but its long-term effectiveness needs to be further followed up.
Source: Obesity Surgery - Category: Surgery Source Type: research
ConclusionCurrent network meta ‐analysis indicated that BPD or mini‐GBP achieved higher diabetes remission rates than the other procedures. However, the result needs to be interpreted with caution considering that these procedures were in the minority of bariatric surgeries.
Source: Obesity Reviews - Category: Eating Disorders & Weight Management Authors: Tags: Obesity Surgery/Obesity Comorbidity Source Type: research
More News: Diabetes | Diabetes Mellitus | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Gastrectomy | Gastroenterology | India Health | Insulin | Laparoscopy | Obesity | Study | Surgery | Weight Loss